ClassID:

242965

Y10S530/826 - CPC Classification

Classification description:

Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof; Proteins from microorganisms Viruses

Recent Application in this class:
#1
20160075745
2016-03-17

Mitochondrial proteins constructs and uses thereof

#2
20150044273
2015-02-12

Viral fusion protein treatment for CCR8 mediated diseases

#3
20140308262
2014-10-16

Mitochondrial proteins constructs and uses thereof

#4
20140243256
2014-08-28

Arenavirus inhibiting peptides and uses therefor

#5
20120270208
2012-10-25

SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES TO HEPATITIS C VIRUS

#6
20120070456
2012-03-22

POLYPEPTIDE CARRIER PROTEIN

#7
20110275146
2011-11-10

FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS

#8
20100291680
2010-11-18

METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION

#9
20100291037
2010-11-18

IMMUNOGENICITY USING A COMBINATION OF DNA AND VACCINIA VIRUS VECTOR VACCINES

#10
20100080818
2010-04-01

Expression and Characterization of HIV-1 Envelope Protein Associated with Broadly Cross Reactive Neutralizing Antibody Response

#11
20100010200
2010-01-14

Antibodies against interleukin-18 binding protein, their preparation and use

#12
20090227770
2009-09-10

Polypeptide carrier protein

#13
20080318275
2008-12-25

Hepatitis C virus asialoglycoproteins

#14
20080262211
2008-10-23

Hepatitis-C virus type 4, 5 and 6

#15
20080187933
2008-08-07

HDV nucleic acid molecules, fragments and applications thereof

#16
20080167199
2008-07-10

Multimerization of HIV-1 Vif protein as a therapeutic target

#17
20080107672
2008-05-08

Hepatitis B virus surface antigen mutant and methods of detection thereof

#18
20070202123
2007-08-30

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

#19
20070160630
2007-07-12

Hepatitis-C virus type 4, 5 and 6

#20
20070160620
2007-07-12

Immune responses using compositions containing stress proteins

#21
20070154883
2007-07-05

Soluble rubella E1 envelope protein variants

#22
20070106062
2007-05-10

Attenuated vif DNA immunization cassettes for genetic vaccines

#23
20070037141
2007-02-15

Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission

#24
20070014813
2007-01-18

Conserved motif of hepatitis C virus E2/NS1 region

#25
20070009549
2007-01-11

HIV-1 protein associated with broadly reactive neutralizing antibody response

#26
20070003566
2007-01-04

Polyepitope carrier protein

#27
20060275323
2006-12-07

Particles of HCV envelope proteins: use for vaccination

#28
20060269953
2006-11-30

Novel hepatitis B virus

#29
20060240042
2006-10-26

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

#30
20060216306
2006-09-28

Epitopes of human immunodeficiency virus-1

#31
20060204986
2006-09-14

Immunogen

#32
20060154294
2006-07-13

Interleukin-18 binding proteins, their preparation and use

#33
20060147468
2006-07-06

Inactivated influenza virus vaccine for nasal or oral application

#34
20060008467
2006-01-12

Human immunodeficiency virus vaccine

#35
20050238659
2005-10-27

Vaccine and method of use

#36
20050232897
2005-10-20

Mucosal cytotoxic T lymphocyte responses

#37
20050221297
2005-10-06

Diagnostic reagent for hepatitis C virus infection

#38
20050221296
2005-10-06

Hepatitis-C virus type 4, 5 and 6

#39
20050202044
2005-09-15

Immune responses using compositions containing stress proteins

#40
20050196413
2005-09-08

Inactivated influenza virus vaccine for nasal or oral application

#41
20050153891
2005-07-14

Viral protein binding compositions and methods

#42
20050112136
2005-05-26

Immunogenic composition

#43
20050107587
2005-05-19

HDV nucleic acid molecules and applications thereof

#44
20050089843
2005-04-28

Antibodies to hepatitis C virus asialoglycoproteins

#45
20050058626
2005-03-17

Expression library immunization

#46
20050053616
2005-03-10

HIV-1 peptide, antigen, immunogenic composition, diagnostic method and immunoassay kit

#47
20050032047
2005-02-10

Hepatitis-C virus type 4, 5, and 6

#48
20050032039
2005-02-10

HIV-specific T-cell induction

#49
20050003345
2005-01-06

Synthetic antigens for the detection of antibodies to hepatitis C virus